| Cat.No. | Name | Information |
|---|---|---|
| M1806 | PD 0332991 HCL | PD-0332991 HCl is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM in cell-free assays, respectively. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. |
| M1974 | Roscovitine (Seliciclib) | Roscovitine is a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. |
| M2112 | LY2835219 mesylate | LY2835219 mesylate is an orally available inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively. |
| M1807 | SCH727965 (dinaciclib) | SCH727965 (Dinaciclib) is a potent and selective CDK inhibitor with IC50 values of 1, 1, 3 and 4 nM for CDK2, CDK5, CDK1 and CDK9, respectively. |
| M3519 | PHA-848125 | PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. |
| M5228 | THZ1 | THZ1 is a covalent CDK7 inhibitor which has the unprecedented ability to target a remote cysteine residue located outside of the canonical kinase domain, providing an unanticipated means of achieving selectivity for CDK7. |
| M1710 | Flavopiridol | Flavopiridol (Alvocidib) is a competitive broad-spectrum CDK inhibitor with IC50 of 30,170,100 nM against CDK1, CDK2 and CDK4, respectively. |
| M6167 | Palbociclib | Palbociclib is a highly specific inhibitor of Cdk4 (IC50=11 nM) and Cdk6 (IC50=16 nM), having no activity against a panel of 36 additional protein kinases. |
| M5305 | RO-3306 | RO-3306 is an ATP-competitive, and selective CDK1 inhibitor with Ki of 20 nM, >15-fold selectivity against a diverse panel of human kinases. |
| M4889 | Ribociclib succinate (LEE011 succinate) | Ribociclib succinate (LEE011 succinate) is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
| M21214 | AS-0141 | AS-0141 (Cdc7-IN-6) is a potent Cdc7 kinase inhibitor (IC50=4 nM) with antitumor activity as described in WO2019165473A1, compound I-D. Cdc7 is a serine threonine protein kinase enzyme that is essential for the initiation of DNA replication during the cell cycle. |
| M21177 | (-)-Enitociclib | (-)-Enitociclib ((-)-BAY-1251152) is an enantiomer of BAY-1251152 with a (-) spin. BAY-1251152 is a potent and highly selective inhibitor of cell cycle-dependent protein kinase (PTEF/CDK9). |
| M21041 | MS140 | MS140 is a specific and highly potent CDK4/6 kinase inhibitor and also a CDK4/6 degrader (PROTAC). |
| M21040 | BSJ-4-116 | BSJ-4-116 is a specific degrader of cyclin-dependent kinase 12 (CDK12). BSJ-4-116 exhibits potent antiproliferative effects. |
| M21000 | LY3405105 | LY3405105 is an orally active CDK7 inhibitor with an IC50 of 92.8 nM. LY3405105 shows potential antineoplastic activity. |
| M20650 | SEL120-34A | SEL120-34A is a novel inhibitor of Cyclin-dependent kinase 8 (CDK8) with IC50 values of 4.4 nM and 10.4 nM for CDK8/Cyclin C and CDK19/CyclinC respectively. |
| M20357 | WAY-352563 | WAY-352563 is a CDK9 inhibitor. |
| M20332 | WAY-383487 | WAY-383487 is a CDK9 inhibitor. |
| M20326 | WAY-381332 | WAY-381332 is a Mimetic CDK9 inhibitor. |
| M20323 | WAY-643018 | WAY-643018 is a CDK1, CDK2, and CDK4 inhibitor. |
| M20271 | WAY-652641 | WAY-652641 is a CDK inhibitor. |
| M20265 | WAY-648936 | WAY-648936 is a CDK1, CDK2, and CDK4 inhibitor. |
| M20262 | WAY-647729 | WAY-647729 is a CDK9 inhibitor. |
| M20258 | WAY-642481 | WAY-642481 is a CDK9 inhibitor. |
| M20243 | WAY-635319 | WAY-635319 is a CDK9 inhibitor. |
| M20234 | WAY-632896 | WAY-632896 is a Mimetic CDK9 inhibitor |
| M20205 | WAY-612622 | WAY-612622 is a CDK9 inhibitor. |
| M20187 | WAY-601323 | WAY-601323 is a Mimetic CDK9 inhibitor. |
| M20161 | WAY-351812 | WAY-351812 is a Novel CDK8 inhibitor. |
| M20152 | WAY-347626 | WAY-347626 is a potential CDK2 inhibitor isosteres. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
